Matthew T. Warkentin

Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model

Rayjean J. Hung, Matthew T. Warkentin, Yonathan Brhane et al. · Cancer Research · 2021 · 95 citations · Full text

Medicine, Biostatistics, Oncology +17

Radiomics analysis to predict pulmonary nodule malignancy using machine learning approaches

Matthew T. Warkentin, Hamad Al‐Sawaihey, Stephen Lam et al. · Thorax · 2024 · 85 citations · Full text

Medicine, Radiology, Diagnostic Radiology +6

Intermittent androgen suppression for prostate cancer: Canadian Prospective Trial and related observations.

Nicholas Bruchovsky, L.H. Klotz, Marianne D. Sadar et al. · PubMed · 2000 · 81 citations

Medicine, Endocrinology, Oncology +17

Determinants of impaired lung function and lung cancer prediction among never-smokers in the UK Biobank cohort

Matthew T. Warkentin, Stephen Lam · EBioMedicine · 2019 · 56 citations · Full text

Medicine, Oncology, Epidemiology +16

Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility

Linda Kachuri, Mattias Johansson, Sara R. Rashkin et al. · Nature Communications · 2020 · 45 citations · Full text

Medicine, Genetics, Oncology +11